Allogeneic chondrogenically differentiated human bone marrow stromal cells do not induce dendritic cell maturation. (20th June 2018)

• Record Type: Journal Article
• Authors: Kiernan, C.H.; KleinJan, A.; Peeters, M.; Wolvius, E.B.; Farrell, E.; Brama, P.A.J.
• Is Part Of: Journal of tissue engineering and regenerative medicine. Volume 12:Number 6(2018)
• Page Start: 1530
• Page End: 1540
• Publication Date: 2018-06-20
• Subjects: allogeneic -- chondrogenesis -- dendritic cell -- endochondral ossification -- immunogenicity -- mesenchymal stem cell; Tissue engineering -- Periodicals; Regeneration (Biology) -- Periodicals; 610.28
• DOI: 10.1002/term.2682
• Languages: English
• ISSNs: 1932-6254

Abstract

Abstract: Bone marrow stromal cell (BMSC)‐mediated endochondral bone formation may be a promising alternative to the current gold standards of autologous bone transplantation, in the development of novel methods for bone repair. Implantation of chondrogenically differentiated BMSCs leads to bone formation in vivo via endochondral ossification. The success of this bone formation in an allogeneic system depends upon the interaction between the implanted constructs and the host immune system. The current study investigated the effect of chondrogenically differentiated human bone marrow stromal cell (hBMSC) pellets on the maturation and function of dendritic cells (DCs) by directly coculturing bone forming chondrogenic hBMSC pellets and immature or lipopolysaccharide (LPS)‐matured DCs in vitro. Allogeneic chondrogenic hBMSC pellets did not affect the expression of CD80, CD86, or HLADR on immature or LPS‐matured DCs following 24, 48, or 72 hr of coculture. Furthermore, they did not induce or inhibit antigen uptake or migration of the DCs over time. IL‐6 was secreted by allogeneic chondrogenic hBMSC pellets in response to LPS‐matured DCs. Overall, this study has demonstrated that maturation of immature DCs was not influenced by allogeneic chondrogenic hBMSC pellets. This suggests that allogeneic chondrogenic hBMSC pellets do not stimulate immunogenic responses from DCs in vitro and are not expected to indirectly activate T cells via DCs. For this reason, allogeneic chondrogenic bone marrow stromal cell pellets are promising candidates for future tissue engineering strategies utilising allogeneic cells for bone repair.